Hemab Therapeutics (COAG) Stock Price, News & Analysis

Company Overview

Key Stats

• Today's Range: $23.48 to $25.25
• 50-Day Range: N/A
• 52-Week Range: $23.48 to $36.61
• Volume: 79,682 shs
• Average Volume: 369,810 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

COAG Stock Analysis - Frequently Asked Questions

How have COAG shares performed this year?

Hemab Therapeutics' stock was trading at $34.00 at the start of the year. Since then, COAG stock has decreased by 26.5% and is now trading at $25.00.

When did Hemab Therapeutics IPO?

Hemab Therapeutics (COAG) raised $285 million in an initial public offering on Friday, May 1st 2026. The company issued 16,750,000 shares at $16.00-$18.00 per share.

When does Hemab Therapeutics' quiet period expire?

Hemab Therapeutics's quiet period expires on Wednesday, June 10th. Hemab Therapeutics had issued 16,750,000 shares in its initial public offering on May 1st. The total size of the offering was $301,500,000 based on an initial share price of $18.00. During Hemab Therapeutics' quiet period, insiders and underwriters that worked on the IPO are prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Hemab Therapeutics?

Shares of COAG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:COAG
• CIK: 2114044
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A